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CORRECTION
Correction: Silymarin in non-cirrhotics with
non-alcoholic steatohepatitis: A randomized,
double-blind, placebo controlled trial
Victor J. Navarro, Steven H. Belle, Massimo D’Amato, Nezam Afdhal, Elizabeth M. Brunt,
Michael W. Fried, K. Rajender Reddy, Abdus S. Wahed, Stephen Harrison, on behalf of the
Silymarin in NASH and C Hepatitis (SyNCH) Study Group
The fourth author’s name is incorrect. The correct name is Nezam Afdhal. The correct citation
is: Navarro VJ, Belle SH, D’Amato M, Afdhal N, Brunt EM, Fried MW, et al. (2019) Silymarin
in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo
controlled trial. PLoS ONE 14(9): e0221683. https://doi.org/10.1371/journal.pone.0221683
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